The Effects of Carperitide on Short and Long-Term Prognosis in Patients With Both Cardiac and Renal Failure.
Phase of Trial: Phase IV
Latest Information Update: 21 Jul 2011
At a glance
- Drugs Carperitide (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 21 Jul 2011 Status changed from not yet recruiting to discontinued as reported by ClinicalTrials.gov.
- 04 Feb 2009 Planned end date changed from 1 May 2012 to 1 May 2013 as reported by ClinicalTrials.gov.